Parotid carcinoma as a second malignancy after treatment of childhood acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 6, 1999, Pages 535-538

  Prasannan, Latha ^a   Pu, Anthony ^b   Hoff, Paul ^a   Weatherly, Robert ^a   Castle, Valerie ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Sutter Medical Center   (United States)

Author keywords

Acute lymphoblastic leukemia; Mucoepidermoid carcinoma; Parotid gland; Second malignancy

Indexed keywords

ASPARAGINASE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER RISK; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; SECOND CANCER; TREATMENT OUTCOME;

EID: 0033504059     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199911000-00017     Document Type: Article

References (27)

1. Rivera GK, Pinkel D, Simone JV, et al. Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med 1993;329:1289-95.
2. Bleyer WA. The U.S. pediatric cancer clinical trials programmes: International implications and the way forward. Eur J Cancer 1997;33:1439-47.
3. Meadows AT, Hobbie WL. The medical consequences of cure. Cancer 1986;58:524-8.
4. Mike V, Meadows AT, D'Angio GJ. Incidence of second malignant neoplasms in children: Results of an international study. Lancet 1982;2:1326.
5. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991;325:1330-6.
6. Robison LL, Mertens A. Second tumors after treatment of childhood malignancies. Hematol Oncol Clin North Am 1993;7:401-15.
7. Meadows AT, Strong LC, Li FP, et al. Bone sarcoma as a second malignant neoplasm in children: Influence of radiation and genetic predisposition for the Late Effects Study Group. Cancer 1980;46: 2603-6.
8. Hawkins MM, Wilson LM, Burton HS, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996;88(5):270-8.
9. Gilchrist GS, Tubergen DG, Sather HN, et al. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: A Childrens Cancer Group report. J Clin Oncol 1994; 12:2594-600.
10. Tubergen DG, Gilchrist GS, O'Brien RT, et al. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: A Childrens Cancer Group report. J Clin Oncol 1993;11:520-6.
11. Coccia PG, Bleyer WA, Siegel SE, et al. Development and preliminary findings of Childrens Cancer Study Group Protocols (#161, 162, 163) for low, average, and high risk acute lymphoblastic leukemia in children. In: Murphy S, Gilbert JR, eds. Leukemia research: advances in cell biology and treatment. North Holland: Elsevier, 1983:241-50.
12. Myer CM 3rd. Second primary malignancies of the head and neck in children. Am J Otolaryngol 1995;16(6):415-7.
13. van der Does-van den Berg A, de Vaan GA, van Weerden JF, et al. Late effects among long-term survivors of childhood acute leukemia in the Netherlands: A Dutch Childhood Leukemia Study Group Report. Pediatr Res 1995;38:802-7.
14. Rosso P, Terracini B, Fears TR, et al. Second malignant tumors after elective end of therapy for a first cancer in childhood: A multicenter study in Italy. Int J Cancer 1994;59:451-6.
15. Kimball Dalton VM, Gelber RD, Li F, et al. Second malignancies in patients treated for childhood acute lymphoblastic leukemia. J Clin Oncol 1998;16:2848-53.
16. Foreman NK, Laitt RD, Chambers EJ, et al. Intracranial large vessel vasculopathy and anaplastic meningioma 19 years after cranial irradiation for acute lymphoblastic leukaemia. Med Pediatr Oncol 1995;24:265-8.
17. Arico M, Bossi G, Cecchetto G, et al. Unusual secondary tumors after childhood lymphoid malignancy. Med Pediatr Oncol 1995; 24:197-9.
18. Soslow R, Davis R, Warnke R, et al. True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood 1996;87: 5207-12.
19. Kuefer M, Moinuddin M, Heideman RL, et al. Papillary thyroid carcinoma: Demographics, treatment, and outcome in eleven pediatric patients treated at a single institution. Med Pediatr Oncol 1997;28:433-40.
20. van der Waal RI, Veerman AJ, Snow GB, et al. Oral squamous cell carcinoma following treatment of acute lymphoblastic leukemia. J Oral Pathol Med 1997;26(2):98-9.
21. Shaw MP, Wallace WH, Eden OB. Spindle cell carcinoma of the tongue in a long-term survivor of child acute lymphoblastic leukemia. Pediatr Hematol Oncol 1997;14:79-83.
22. Loy TS, McLaughlin R, Odom LF, et al. Mucoepidermoid carcinoma of the parotid as a second malignant neoplasm in children. Cancer 1989;64:2174-77.
23. Tucker MA, Coleman CN, Cox RS, et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988;318:76-81.
24. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 1994;12:312-25.
25. Myer C, Cotton RT. Salivary gland disease in children: A review. Clin Pediatr 1986;25:314-57.
26. Castro EB, Huvos AG, Strong EW, et al. Tumors of the major salivary glands in children. Cancer 1972;29:312-7.
27. Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 1992;69:616-9.